RxRevu, a provider of medication cost transparency solutions to identify cost-saving opportunities on prescription drugs, closed its Series B funding round of $7 million. JAZZ


RxRevu, a provider of medication cost transparency solutions to identify cost-saving opportunities on prescription drugs, closed its Series B funding round of $7 million. JAZZ

Sidecar Health, a California-based insurance startup focused on price transparency and direct payments for care, raised $125 million in its Series C funding round at

Prescryptive Health, a prescription medication price transparency app that provides data on prescription drug coverage and costs, closed a $26 million Series A financing round.